Tissue inhibitors of metalloproteinases: evolution, structure and function.

[1]  R. Williamson,et al.  The Specificity of TIMP-2 for Matrix Metalloproteinases Can Be Modified by Single Amino Acid Mutations* , 1999, The Journal of Biological Chemistry.

[2]  Robert Blelloch,et al.  Control of organ shape by a secreted metalloprotease in the nematode Caenorhabditis elegans , 1999, Nature.

[3]  H. Erdjument-Bromage,et al.  Tissue inhibitor of metalloproteinase-2 stimulates mesenchymal growth and regulates epithelial branching during morphogenesis of the rat metanephros. , 1999, The Journal of clinical investigation.

[4]  T. Godenschwege,et al.  Invertebrate tissue inhibitor of metalloproteinase: structure and nested gene organization within the synapsin locus is conserved from Drosophila to human. , 1999, Genomics.

[5]  U. Thorgeirsson,et al.  Tissue inhibitor of metalloproteinases-1 (TIMP-1) binds to the cell surface and translocates to the nucleus of human MCF-7 breast carcinoma cells. , 1999, Biochemical and biophysical research communications.

[6]  K. Brew,et al.  Residue 2 of TIMP-1 Is a Major Determinant of Affinity and Specificity for Matrix Metalloproteinases but Effects of Substitutions Do Not Correlate with Those of the Corresponding P1′ Residue of Substrate* , 1999, The Journal of Biological Chemistry.

[7]  A. Baker,et al.  ©1999 Cancer Research Campaign Article no. bjoc.1998.0217 Inhibition of invasion and induction of apoptotic cell , 2022 .

[8]  G. Schneider,et al.  Three-dimensional structure of human tissue inhibitor of metalloproteinases-2 at 2.1 A resolution. , 1998, Journal of molecular biology.

[9]  Y. Itoh,et al.  Plasma Membrane-bound Tissue Inhibitor of Metalloproteinases (TIMP)-2 Specifically Inhibits Matrix Metalloproteinase 2 (Gelatinase A) Activated on the Cell Surface* , 1998, The Journal of Biological Chemistry.

[10]  P. Slocombe,et al.  TNF‐α converting enzyme (TACE) is inhibited by TIMP‐3 , 1998 .

[11]  J. Calvete,et al.  Crystal structure of the complex formed by the membrane type 1‐matrix metalloproteinase with the tissue inhibitor of metalloproteinases‐2, the soluble progelatinase A receptor , 1998, The EMBO journal.

[12]  H. Nagase.  Cell surface activation of progelatinase A (proMMP-2) and cell migration , 1998, Cell Research.

[13]  R. Williamson,et al.  High Resolution Structure of the N-terminal Domain of Tissue Inhibitor of Metalloproteinases-2 and Characterization of Its Interaction Site with Matrix Metalloproteinase-3* , 1998, The Journal of Biological Chemistry.

[14]  M. Stetler-Stevenson,et al.  Tissue inhibitor of metalloproteinase (TIMP)-1 induces differentiation and an antiapoptotic phenotype in germinal center B cells. , 1998, Blood.

[15]  N. Ohba,et al.  A novel splice site mutation in the tissue inhibitor of the metalloproteinases-3 gene in Sorsby’s fundus dystrophy with unusual clinical features , 1998, Human Genetics.

[16]  K. Brocklehurst,et al.  Kinetic analysis of the mechanism of interaction of full-length TIMP-2 and gelatinase A: evidence for the existence of a low-affinity intermediate. , 1998, Biochemistry.

[17]  M. Barker,et al.  Localization of the Functional Domains of Human Tissue Inhibitor of Metalloproteinases-3 and the Effects of a Sorsby’s Fundus Dystrophy Mutation* , 1998, The Journal of Biological Chemistry.

[18]  Y. Okada,et al.  TIMP-2 Promotes Activation of Progelatinase A by Membrane-type 1 Matrix Metalloproteinase Immobilized on Agarose Beads* , 1998, The Journal of Biological Chemistry.

[19]  T. Hoshino,et al.  Cell cycle-associated accumulation of tissue inhibitor of metalloproteinases-1 (TIMP-1) in the nuclei of human gingival fibroblasts. , 1998, Journal of cell science.

[20]  A. Baker,et al.  Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis. , 1998, The Journal of clinical investigation.

[21]  M. Cilli,et al.  TIMP‐2 over‐expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis , 1998 .

[22]  Gillian Murphy,et al.  The TIMP2 Membrane Type 1 Metalloproteinase “Receptor” Regulates the Concentration and Efficient Activation of Progelatinase A , 1998, The Journal of Biological Chemistry.

[23]  V. Kähäri,et al.  High level expression of tissue inhibitors of metalloproteinases-1,-2 and -3 in melanoma cells achieved by adenovirus mediated gene transfer. , 1998, Advances in experimental medicine and biology.

[24]  K. Taylor,et al.  Replacement of Conserved Cysteines in Human Tissue Inhibitor of Metalloproteinases-1* , 1997, The Journal of Biological Chemistry.

[25]  R. Fridman,et al.  Kinetic Analysis of the Binding of Human Matrix Metalloproteinase-2 and -9 to Tissue Inhibitor of Metalloproteinase (TIMP)-1 and TIMP-2* , 1997, The Journal of Biological Chemistry.

[26]  R. Williamson,et al.  Mapping the binding site for matrix metalloproteinase on the N-terminal domain of the tissue inhibitor of metalloproteinases-2 by NMR chemical shift perturbation. , 1997, Biochemistry.

[27]  N. Colburn,et al.  TIMP-3 induces cell death by stabilizing TNF-alpha receptors on the surface of human colon carcinoma cells. , 1997, Cytokine.

[28]  D. Gomez,et al.  Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. , 1997, European journal of cell biology.

[29]  R. Huber,et al.  Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1 , 1997, Nature.

[30]  K. Brew,et al.  Mutational Study of the Amino-terminal Domain of Human Tissue Inhibitor of Metalloproteinases 1 (TIMP-1) Locates an Inhibitory Region for Matrix Metalloproteinases* , 1997, The Journal of Biological Chemistry.

[31]  S. Sheng,et al.  Preparation and Characterization of Recombinant Tissue Inhibitor of Metalloproteinase 4 (TIMP-4)* , 1997, The Journal of Biological Chemistry.

[32]  K. Suzuki,et al.  Involvement of a region near valine-69 of tissue inhibitor of metalloproteinases (TIMP)-1 in the interaction with matrix metalloproteinase 3 (stromelysin 1). , 1997, The Biochemical journal.

[33]  C. Overall,et al.  Specific, High Affinity Binding of Tissue Inhibitor of Metalloproteinases-4 (TIMP-4) to the COOH-terminal Hemopexin-like Domain of Human Gelatinase A , 1997, The Journal of Biological Chemistry.

[34]  P. Soloway,et al.  Assessment of the role of tissue inhibitor of metalloproteinase-1 (TIMP-1) during the periovulatory period in female mice lacking a functional TIMP-1 gene. , 1997, Biology of reproduction.

[35]  H. Nagase.  Activation mechanisms of matrix metalloproteinases. , 1997, Biological chemistry.

[36]  G. Murphy,et al.  Relating matrix metalloproteinase structure to function: why the "hemopexin" domain? , 1997, Matrix biology : journal of the International Society for Matrix Biology.

[37]  G. Butler,et al.  Membrane-type-2 matrix metalloproteinase can initiate the processing of progelatinase A and is regulated by the tissue inhibitors of metalloproteinases. , 1997, European journal of biochemistry.

[38]  S. Dey,et al.  Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the mouse uterus during the peri-implantation period. , 1997, Developmental genetics.

[39]  R. Williamson,et al.  Chemically and conformationally authentic active domain of human tissue inhibitor of metalloproteinases-2 refolded from bacterial inclusion bodies. , 1996, European journal of biochemistry.

[40]  K. Taylor,et al.  The Mechanism of Inhibition of Collagenase by TIMP-1* , 1996, The Journal of Biological Chemistry.

[41]  N. Colburn,et al.  Suppression of in vivo tumor growth and induction of suspension cell death by tissue inhibitor of metalloproteinases (TIMP)-3. , 1996, Carcinogenesis.

[42]  G. Butler,et al.  The Soluble Catalytic Domain of Membrane Type 1 Matrix Metalloproteinase Cleaves the Propeptide of Progelatinase A and Initiates Autoproteolytic Activation , 1996, The Journal of Biological Chemistry.

[43]  K. Brew,et al.  Folding and characterization of the amino‐terminal domain of human tissue inhibitor of metalloproteinases‐1 (TIMP‐1) expressed at high yield in E. coli , 1996, FEBS letters.

[44]  M. Lim,et al.  The roles of tissue inhibitors of metalloproteinases in tissue remodelling and cell growth. , 1996, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[45]  C. López-Otín,et al.  Biochemical Characterization of Human Collagenase-3 (*) , 1996, The Journal of Biological Chemistry.

[46]  N. Bersch,et al.  Metalloproteinase inhibition and erythroid potentiation are independent activities of tissue inhibitor of metalloproteinases-1. , 1995, Blood.

[47]  Hiroshi Sato,et al.  Identification of the Second Membrane-type Matrix Metalloproteinase (MT-MMP-2) Gene from a Human Placenta cDNA Library , 1995, The Journal of Biological Chemistry.

[48]  V. Papadopoulos,et al.  Identification of a stimulator of steroid hormone synthesis isolated from testis. , 1995, Science.

[49]  A. Strongin,et al.  Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase , 1995, The Journal of Biological Chemistry.

[50]  G Murphy,et al.  Tissue inhibitors of matrix metalloendopeptidases. , 1995, Methods in enzymology.

[51]  R. Williamson,et al.  Solution structure of the active domain of tissue inhibitor of metalloproteinases-2. A new member of the OB fold protein family. , 1994, Biochemistry.

[52]  A. Shinagawa,et al.  Cell growth-promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2). , 1994, Journal of cell science.

[53]  Motoharu Seiki,et al.  A matrix metalloproteinase expressed on the surface of invasive tumour cells , 1994, Nature.

[54]  W. Stetler-Stevenson,et al.  Tissue inhibitor of metalloproteinases‐2 inhibits bFGF‐induced human microvascular endothelial cell proliferation , 1993, Journal of cellular physiology.

[55]  P. Slocombe,et al.  The activity of the tissue inhibitors of metalloproteinases is regulated by C-terminal domain interactions: a kinetic analysis of the inhibition of gelatinase A. , 1993, Biochemistry.

[56]  A. Murzin.  OB(oligonucleotide/oligosaccharide binding)‐fold: common structural and functional solution for non‐homologous sequences. , 1993, The EMBO journal.

[57]  S. Hawkes,et al.  Role of the 21-kDa protein TIMP-3 in oncogenic transformation of cultured chicken embryo fibroblasts. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[58]  N. Pavloff,et al.  A new inhibitor of metalloproteinases from chicken: ChIMP-3. A third member of the TIMP family. , 1992, The Journal of biological chemistry.

[59]  A. Strongin,et al.  Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. , 1992, The Journal of biological chemistry.

[60]  K. Iwata,et al.  Growth‐promoting activity of tissue inhibitor of metalloproteinases‐1 (TIMP‐1) for a wide range of cells A possible new growth factor in serum , 1992, FEBS letters.

[61]  W. Stetler-Stevenson,et al.  Tissue inhibitor of metalloproteinase‐2 (TIMP‐2) has erythroid‐potentiating activity , 1992, FEBS letters.

[62]  A. Eisen,et al.  Growth stimulation of human keratinocytes by tissue inhibitor of metalloproteinases. , 1991, The Journal of investigative dermatology.

[63]  R. Williamson,et al.  The N-terminal domain of tissue inhibitor of metalloproteinases retains metalloproteinase inhibitory activity. , 1991, Biochemistry.

[64]  C. Overall,et al.  Concanavalin A produces a matrix-degradative phenotype in human fibroblasts. Induction and endogenous activation of collagenase, 72-kDa gelatinase, and Pump-1 is accompanied by the suppression of the tissue inhibitor of matrix metalloproteinases. , 1990, The Journal of biological chemistry.

[65]  H. Morris,et al.  Disulphide bond assignment in human tissue inhibitor of metalloproteinases (TIMP). , 1990, The Biochemical journal.

[66]  P. Stephens,et al.  Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity , 1985, Nature.

[67]  E. Brown,et al.  Molecular characterization and expression of the gene encoding human erythroid-potentiating activity , 1985, Nature.

[68]  B. Hazleman,et al.  The interaction of purified rabbit bone collagenase with purified rabbit bone metalloproteinase inhibitor. , 1983, The Biochemical journal.